NCT02235285

Brief Summary

In 162 Asian patients, primary breast augmentations were performed by a single surgeon during 5 years. The purpose of this study evaluates Asian outcomes in primary breast augmentation using single antibiotic breast irrigation by a single surgeon's practice and examines the comparison of Asian and Western outcomes in primary breast augmentation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 5, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 9, 2014

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
9 months until next milestone

Results Posted

Study results publicly available

September 21, 2015

Completed
Last Updated

May 4, 2018

Status Verified

May 1, 2018

Enrollment Period

4.2 years

First QC Date

September 5, 2014

Results QC Date

June 19, 2015

Last Update Submit

May 3, 2018

Conditions

Keywords

capsular contracturereoperationbreast augmentation

Outcome Measures

Primary Outcomes (1)

  • Post Surgical Complications and Reoperation Rate During Breast Augmentation

    The investigators reviewed 162-consecutive patients underwent breast augmentation by one surgeon for reoperation rate.

    5 years

Study Arms (1)

breast augmentation,reoperation

EXPERIMENTAL

A retrospective chart review was performed to examine a total of 162 patients received the same brand of implants for primary breast augmentation under sedative anesthesia (propofol infusion) in a single surgeon's practice.

Procedure: primary breast augmentation

Interventions

With the patient under sedative anesthesia, wide preparation and draping by using povidone-iodine are performed with using talc-free gloves and povidone-iodine gauze nipple shields. Tumescent solution is infiltrated in the precise plane. Pockets are developed precisely with blunt dissection with fingers and instruments under both direct and indirect visions simultaneously, if needed, with using endoscopy, while careful hemostasis done. After dissection, two pockets are irrigated with 300ml of single antibiotic solution without active evacuation of the irrigation. When re-draping and re-preparation by using povidone-iodine are performed before implant insertion, a new pair of talc-free gloves is used and cleansed with the single antibiotic solution.

breast augmentation,reoperation

Eligibility Criteria

Age22 Years - 57 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • primary case

You may not qualify if:

  • secondary case
  • breast reduction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Department of Plastic Surgery, Winners Clinic

Seoul, 135-893, South Korea

Location

Related Publications (1)

  • Spear SL, Murphy DK, Slicton A, Walker PS; Inamed Silicone Breast Implant U.S. Study Group. Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg. 2007 Dec;120(7 Suppl 1):8S-16S. doi: 10.1097/01.prs.0000286580.93214.df.

    PMID: 18090808BACKGROUND

Results Point of Contact

Title
Dr. Cheol Hwan Kim
Organization
The Department of Plastic Surgery, Winners Clinic

Study Officials

  • CHEOLHWAN KIM, M.D.

    Winners Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2014

First Posted

September 9, 2014

Study Start

January 1, 2010

Primary Completion

April 1, 2014

Study Completion

January 1, 2015

Last Updated

May 4, 2018

Results First Posted

September 21, 2015

Record last verified: 2018-05

Locations